Risankizumab pre-filled syringe used to treat psoriasis and psoriatic arthritis
Contains risankizumab 150 mg, a biologic that blocks interleukin-23, an inflammatory protein, used to treat moderate to severe plaque psoriasis and psoriatic arthritis.
Attributes
Product Content
How to Use:
• Inject subcutaneously as prescribed, usually every 12 weeks after initial doses.
• Rotate injection sites; let the syringe reach room temperature before injecting.
• Report signs of infection to your doctor promptly.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Skyrizi 150mg 1 Prefilled Syringe (Refrigerated) has been copied